Phlow Corp., a U.S.-based public benefit corporation and contract development and manufacturing organization (CDMO), today announced that it has closed a $36 million Series B capital raise as part of its mission to protect America’s medicine cabinet. Since its launch...
Addition of internationally recognized advisors, new board member, and President highlight Phlow’s commitment to create a reliable supply of affordable, high-quality essential medicines and deliver advanced manufacturing expertise to the pharmaceutical industry....
Phlow Corp. and U.S. Pharmacopeia Announce the Opening of Laboratories at the Advanced Pharmaceutical Development Center in Richmond, Virginia Richmond, VA., December 12, 2022 – Today, Phlow Corp., a U.S.-based public benefit corporation and contract development and...
Richmond/Petersburg, VA, September 09, 2022 – Alliance for Building Better Medicine, a coalition of public and private sector stakeholders in the Richmond-Petersburg region, and Governor Glenn Youngkin yesterday honored National Essential Medicine Shortage Awareness...
Solving America’s drug shortage crisis continues to be a complex challenge that will take the effort, collaboration, and innovation of many to solve Richmond, Virginia, September 8, 2022 – Phlow announced today that it will be observing National Essential Medicine...